Nontuberculous mycobacteria isolated during the treatment of pulmonary tuberculosis
|
|
- Sara Norton
- 5 years ago
- Views:
Transcription
1 Respiratory Medicine (2009) 103, 1936e1940 available at journal homepage: Nontuberculous mycobacteria isolated during the treatment of pulmonary tuberculosis Hee-Jung Jun a, Kyeongman Jeon a, Sang-Won Um a, O Jung Kwon a, Nam Yong Lee b, Won-Jung Koh a, * a Division of Pulmonary and Critical Care Medicine, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, 50 Irwon-dong, Gangnam-gu, Seoul , Republic of Korea b Department of Laboratory Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea Received 31 January 2009; accepted 25 May 2009 Available online 2 July 2009 KEYWORDS Atypical mycobacteria; Pulmonary tuberculosis; Lung diseases Summary Background: The significance of nontuberculous mycobacteria (NTM) isolated from a patient during therapy for pulmonary tuberculosis (TB) is uncertain. We investigated the frequency and clinical significance of NTM isolated from patients receiving anti-tb treatment. Methods: We conducted a retrospective cohort study of all patients with culture-confirmed pulmonary TB, and identified patients with respiratory cultures positive for NTM during therapy for pulmonary TB. Results: From January 2003 to December 2005, 958 patients were diagnosed with cultureconfirmed pulmonary TB. NTM were isolated from 113 specimens in 68 (7.1%) patients during anti-tb treatment. The most frequently isolated NTM species were Mycobacterium abscessus (n Z 35, 31%), Mycobacterium fortuitum (n Z 17, 15%), Mycobacterium avium complex (n Z 9, 8%), and Mycobacterium gordonae (n Z 9, 8%). Forty-eight (71%) patients had only one positive culture, while 20 (29%) had two or more positive cultures for NTM. Only two (3%) patients who had two or more positive culture after anti-tb treatment showed the same NTM species, which were M. abscessus. Conclusion: The isolation of NTM in patients with pulmonary TB is not uncommon during anti- TB treatment. However, this is likely the result of colonization, a transient infection, or specimen contamination. The co-existence of pulmonary TB and NTM lung disease may be rare but should be considered in patients with relatively virulent NTM species such as M. abscessus. ª 2009 Elsevier Ltd. All rights reserved. Abbreviations: NTM, nontuberculous mycobacteria; ATS, American Thoracic Society; IDSA, Infectious Diseases Society of America; TB, tuberculosis; AFB, acid-fast bacilli; HIV, human immunodeficiency virus; IQR, interquartile range. * Corresponding author. Tel.: þ ; fax: þ address: wjkoh@skku.edu (W.-J. Koh) /$ - see front matter ª 2009 Elsevier Ltd. All rights reserved. doi: /j.rmed
2 NTM isolated during treatment of pulmonary TB 1937 Introduction Mycobacteria other than Mycobacterium tuberculosis complex and Mycobacterium leprae are collectively referred to as nontuberculous mycobacteria (NTM). 1e3 Human disease resulting from NTM infection is classified into four distinct clinical syndromes: pulmonary disease, lymphadenitis, cutaneous disease, and disseminated disease. Among these, chronic pulmonary disease is the most common localized clinical condition. 1e3 Studies have demonstrated that disease attributable to NTM is on the rise. NTM are responsible for an increasing proportion of mycobacterial diseases in many developed and developing countries. 4e8 NTM are ubiquitous organisms and are frequently isolated from environmental sources, including surface water, tap water, and soil. 1,2,9 Accordingly, the isolation of NTM species from a respiratory sample is insufficient evidence for the presence of NTM lung disease. Some patients are infected with NTM without evidence of pulmonary disease, and such infection may indicate colonization or transient infection. Therefore, the diagnosis of NTM lung disease must rely on clinical, radiographic, and microbiological criteria. The American Thoracic Society (ATS) issued diagnostic criteria for NTM lung disease in 1997, 1 and the ATS and the Infectious Diseases Society of America (IDSA) recently revised the criteria in The guidelines state that the reasonable exclusion of other etiologies of pulmonary disease is a necessary clinical criterion, along with the presence of respiratory symptoms, compatible radiographic abnormalities, and bacteriological evidence of NTM. 2 Furthermore, the guidelines state that there are clinical problems not directly addressed by the diagnostic guidelines; one of these is the significance of NTM isolated from a patient during therapy for pulmonary tuberculosis (TB). To date, only a few reports of cases in Japan with concurrent TB and NTM infections have been published. 10e14 However, the frequency and clinical significance of NTM isolated from patients during treatment for pulmonary TB are not well studied. Therefore, we investigated the frequency and clinical significance of NTM isolated from patients receiving anti-tb treatment. Patients and methods Study subjects We conducted a retrospective cohort study of all patients with culture-confirmed pulmonary TB who had been diagnosed and treated at Samsung Medical Center from January 2003 through December Samsung Medical Center is a 1250-bed university-affiliated tertiary referral hospital in Seoul, South Korea. Among these patients, those with respiratory cultures positive for NTM during therapy for pulmonary TB were identified from a computer-assisted search of medical records. The Institutional Review Board at Samsung Medical Center approved the study protocol. Informed consent was waived because of the retrospective nature of the study. Smears, cultures, and species identification Generally, the patients with pulmonary TB were treated on an outpatient basis. Sputum smear and culture examinations were performed monthly for the first 2 months and then at 1- to 2-month intervals until the end of treatment. Sputum specimens were collected spontaneously, and tap water was not any part of the specimen processing. Clinical specimens were stained using the ZiehleNeelsen method, according to the ATS guidelines. 15 The results of smear microscopy were reported semi-quantitatively. A positive smear was defined as one with one or more acidfast bacilli (AFB) per 100 high-power fields. Sputum or bronchial wash specimens were decontaminated using the N-acetyl-L-cysteine 2% NaOH method, and the processed specimens were plated on LöwensteineJensen medium. Inoculated tubes were incubated at 37 C and then inspected weekly for 8 weeks. To distinguish between M. tuberculosis and NTM, all AFB isolates were assessed according to growth rates, colony morphology, and pigmentation, as well as with a commercial DNA probe (AMPLICO test; Roche Molecular Systems, Branchburg, NJ). NTM species were identified using a polymerase chain reaction and restriction length polymorphism method based on the rpob gene, as previously described. 6,16,17 Evaluation of clinical and radiographic findings The medical records of the patients were reviewed, with respect to the following information: age, gender, smoking history, underlying pulmonary and non-pulmonary illnesses, results of anti-human immunodeficiency virus (HIV) antibody, AFB smear status, number of positive NTM isolates, species of NTM organisms, and anti-tb treatment information. The extent of radiographic pulmonary TB disease was graded using the U.S. National Tuberculosis and Respiratory Disease Association scheme, which classifies disease into minimal, moderately advanced, and far-advanced disease. 18 Results Patients characteristics From January 2003 to December 2005, 958 patients were diagnosed with culture-confirmed pulmonary TB. Of these, 68 (7.1%) patients were identified as having positive culture results for NTM during anti-tb treatment. The median age of these 68 patients was 52.5 years (interquartile range [IQR], 35.5e64.0 years). Forty-two (62%) of the patients were men and 26 were women. Thirty (44%) patients had never smoked (Table 1). Twenty-three (34%) patients had a history of pulmonary TB. Nine (13%) patients had idiopathic pulmonary fibrosis, and six (9%) had bronchiectasis. Twenty-seven (40%) patients had underlying non-pulmonary disease, including diabetes mellitus, malignancies, chronic liver disease, and chronic kidney disease (Table 1). No patient was seropositive for antibodies to HIV or belonged to a high-risk group (i.e. homosexuals, injectable drug users, persons with hemophilia, or coagulation disorders, etc.).
3 1938 H.-J. Jun et al. Of the 68 patients, 44 (65%) had drug-susceptible TB, 15 (22%) had multidrug-resistant TB, and seven (10%) had any other drug-resistant TB. The results of drug susceptibility tests were not available for two patients. Forty-nine (72%) of the patients had moderately advanced or far-advanced radiographic disease (Table 1). The duration of the anti-tb treatment in the 68 patients was a median of 6.6 months (IQR, 6.0e16.8 months). Microbiological findings During anti-tb treatment in the 68 patients, 799 respiratory specimens were sent to the laboratory for mycobacterial culture, and 113 specimens were found to be positive for NTM. The median number of specimens sent for culture per patient was eight (IQR, 6e16), and the median number of cultures for NTM per patient was one (IQR, 1e2). The median interval from starting anti-tb treatment to the first positive culture for NTM was 2.8 months (IQR, 0.9e5.6 months). Forty-eight (71%) patients had only one positive culture, 13 (19%) patients had two, and seven (10%) patients had three or more cultures positive for NTM. Fifty-three (47%) of the 113 specimen cultures positive culture for NTM were negative on AFB stain, and 94 (83%) specimen cultures resulted in fewer than 50 colonies (Table 2). From the 113 specimens, 114 NTM were isolated and identified, as two different NTM species were isolated from one sputum specimen. In nine cases, M. tuberculosis and NTM were detected from the same sample on sputum culture. Among the 113 specimens, the most frequently isolated organisms were Mycobacterium abscessus (n Z 35, Table 1 Patients characteristics (n Z 68). Variable Value Age (years) 52.5 (35.5e64) Male/female 42 (62%)/26 (38%) Body mass 21.7 (19.6e24.0) index (kg/m 2 ) Underlying lung Previous pulmonary 23 (34%) disease tuberculosis Idiopathic pulmonary 9 (13%) fibrosis Bronchiectasis 6 (9%) Others 6 (9%) Underlying Diabetes mellitus 16 (24%) medical Malignancy 5 (7%) disease Chronic liver disease 3 (4%) Chronic kidney disease 2 (3%) Others 5 (7%) Drug susceptibility test Radiologic severity Drug-susceptible TB 44 (65%) Multidrug-resistant TB 15 (22%) Other drug-resistant TB 7 (10%) Not available 2 (3%) Minimal 19 (28%) Moderately advanced 39 (57%) Far advanced 10 (15%) Data are presented as the median (interquartile range) or number (%). Table 2 AFB smear and culture findings of specimens with cultures positive for NTM (n Z 113). Quantity reported Number (%) AFB smear results AFB culture results 31%), Mycobacterium fortuitum (n Z 17, 15%), Mycobacterium avium complex (n Z 9, 8%), and Mycobacterium gordonae (n Z 9, 8%) (Table 3). Among the 68 patients, the frequently isolated species were, in decreasing order, M. fortuitum (n Z 14, 21%), M. abscessus (n Z 13, 19%), M. avium complex (n Z 8, 12%), and M. gordonae (n Z 8, 12%), Mycobacterium terrae complex (n Z 3, 4%), and Mycobacterium chelonae (n Z 2, 3%). Follow-up culture findings No AFB seen 53 (47%) Doubtful 20 (18%) Rare (1þ) 17 (15%) Few (2þ) 11 (10%) Moderate (3þ) 8 (7%) Numerous (4þ) 4 (3%) Fewer than 50 colonies 94 (83%) 50e100 colonies 12 (11%) 100e200 colonies 2 (2%) 200e500 colonies 4 (3%) (almost confluence) >500 colonies (confluence) 1 (1%) Of the 68 patients, 65 had available follow-up specimens for AFB culture after the first positive NTM culture results. Of these 65 patients, 56 converted to negative cultures for NTM on follow-up sputum cultures during anti-tb treatment. Nine (13%) patients had repeated positive culture results for NTM after the completion of anti-tb treatment. The median duration of follow-up after-tb treatment was 23.9 months (IQR, 15.2e32.0 months) in these nine Table 3 Frequency of NTM isolates. Organisms Isolates (n Z 114) Patients (n Z 68) a Mycobacterium abscessus 35 (31%) 13 (19%) Mycobacterium fortuitum 17 (15%) 14 (21%) Mycobacterium avium complex 9 (8%) 8 (12%) Mycobacterium intracellulare 3 3 M. avium 6 5 Mycobacterium gordonae 9 (8%) 8 (12%) Mycobacterium terrae complex 3 (3%) 3 (4%) Mycobacterium chelonae 3 (3%) 2 (3%) Mycobacterium septicum 2 (2%) 2 (3%) Mycobacterium szulgai 1 (1%) 1 (1.5%) Mycobacterium aubagmense 1 (1%) 1 (1.5%) Mycobacterium nonchromogenicum 1 (1%) 1 (1.5%) Unclassified 10 (9%) 10 (15%) Contamination or loss of isolates 23 (20%) 22 (32%) a More than one NTM species were isolated from some patient, so the sum of frequency was over 68.
4 NTM isolated during treatment of pulmonary TB 1939 patients. Four patients showed negative NTM culture on the last sputum culture, and five patients had positive NTM culture on the last sputum culture. However, only two (3%) patients who had two or more positive culture results after anti-tb treatment grew the same NTM species with those which were isolated during anti-tb treatment. The NTM isolated from these two patients who had persistent positive cultures for NTM during and after anti- TB treatment was M. abscessus. Despite anti-tb treatment for culture-confirmed pulmonary TB, these two patients had respiratory symptoms and compatible radiographic findings (i.e. cavities or multiple bronchiolitis associated with bronchiectasis). M. abscessus was isolated more than five times from these two patients, during and after anti-tb treatment. Therefore, they could be diagnosed with M. abscessus lung disease. However, they did not have demonstrable radiographic progression. So, they were on the regular follow-up without antibiotic treatment for M. abscessus lung disease. The duration of follow-up after anti-tb treatment in these two patients was 32 and 51 months, respectively. Discussion NTM are ubiquitous environmental organisms. Patients with pre-existing lung damage are susceptible to NTM. Therefore, chronic obstructive pulmonary disease, pneumoconiosis, previous pulmonary TB, and bronchiectasis are all associated with NTM lung infection. 1,2 According to the guidelines, the diagnosis of NTM lung disease requires the exclusion of other disorders such as TB and fungal infection. 1,2 Therefore, the significance of NTM isolated from a patient with pulmonary TB or pulmonary fungal disease is uncertain. 2 Recently, NTM infection was reported to be related to Aspergillus-related disease including aspergilloma and chronic necrotizing pulmonary aspergillosis. 19,20 However, the frequency and clinical significance of NTM isolated from patients during treatment for pulmonary TB has not been well studied. Until now, only 10 cases of concurrent M. tuberculosis and NTM infections have been reported in Japan. 10e14 To our knowledge, this is the largest case series describing TB patients with cultures positive for NTM during their anti-tb treatment. We found that 7% of the patients with culture-confirmed pulmonary TB had positive cultures for NTM during anti-tb treatment. About two-thirds (44/68, 65%) of our patients had underlying lung disease other than the diagnosed TB, and 49 (72%) of the patients had moderately advanced or far-advanced pulmonary TB. Therefore, the isolation of NTM from patients with pulmonary TB was not uncommon during anti-tb treatment, at least in our study population. Given that NTM are ubiquitous in nature, positive cultures from human airways may indicate infection, colonization, or specimen contamination. 21 In our study, 71% (48/68) of the patients had a single positive culture for NTM during anti-tb treatment, and only 13% (9/68) had repeated positive cultures for NTM after completing anti-tb treatment. Moreover, only two (3%) patients had two or more positive culture results with the same NTM species after anti-tb treatment. AFB staining of the 113 specimens with cultures positive for NTM revealed that a large number (n Z 73, 65%) of them were smear-negative. In addition, the culture results showed that a large majority of the specimen (n Z 94, 83%) had fewer than 50 colonies. The clinical relevance of this finding is not clear, but it indicates that even when a specimen was positive for NTM, the bacterial burden was low. Interestingly, the most commonly isolated organism in our study, on a per-patient basis, was M. fortuitum, which is a low-virulence NTM. 16 In 18% (12/68) of the patients, NTM species that are usually contaminants, such as M. gordonae and M. terrae complex were isolated. 22 All of these findings suggest that an NTM isolated from a patient during therapy for pulmonary TB is usually the result of colonization (i.e., recovery of organisms more than once without demonstration of specific pulmonary disease), a transient infection (i.e., transient isolation of organisms with subsequent negative cultures and no evidence of disease progression), or specimen contamination, rather than clinically relevant pulmonary infection. Therefore, simple follow-up of sputum culture may be enough at 1- to 2-month intervals until the end of anti-tb treatment in most patients. In conclusion, the isolation of NTM from patients with pulmonary TB is not uncommon during anti-tb treatment. However, this usually represents colonization, a transient infection, or specimen contamination. The co-existence of pulmonary TB and NTM lung disease may be rare, but should be considered in patients with relatively virulent NTM species such as M. abscessus. Conflict of interest statement All authors have no financial or other potential conflicts of interest to disclose. Acknowledgements This work was supported by the Samsung Biomedical Research Institute grant (# SBRI C-A ). References 1. Wallace Jr RJ, Cook JL, Glassroth J, Griffith DE, Olivier KN, Gordin F. American Thoracic Society statement: diagnosis and treatment of disease caused by nontuberculous mycobacteria. Am J Respir Crit Care Med 1997;156:S1e Griffith DE, Aksamit T, Brown-Elliott BA, et al. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med 2007;175:367e Piersimoni C, Scarparo C. Pulmonary infections associated with non-tuberculous mycobacteria in immunocompetent patients. Lancet Infect Dis 2008;8:323e Martin-Casabona N, Bahrmand AR, Bennedsen J, et al. Nontuberculous mycobacteria: patterns of isolation. A multicountry retrospective survey. Int J Tuberc Lung Dis 2004;8: 1186e Wickremasinghe M, Ozerovitch LJ, Davies G, et al. Nontuberculous mycobacteria in patients with bronchiectasis. Thorax 2005;60:1045e51.
5 1940 H.-J. Jun et al. 6. Koh WJ, Kwon OJ, Jeon K, et al. Clinical significance of nontuberculous mycobacteria isolated from respiratory specimens in Korea. Chest 2006;129:341e8. 7. Fowler SJ, French J, Screaton NJ, et al. Nontuberculous mycobacteria in bronchiectasis: prevalence and patient characteristics. Eur Respir J 2006;28:1204e Dailloux M, Abalain ML, Laurain C, et al. Respiratory infections associated with nontuberculous mycobacteria in non-hiv patients. Eur Respir J 2006;28:1211e5. 9. Field SK, Cowie RL. Lung disease due to the more common nontuberculous mycobacteria. Chest 2006;129:1653e Nakagawa Y, Ebihara M, Shimazu K. A case of mixed pulmonary infection with Mycobacterium tuberculosis and M. intracellulare. Kokyu 1997;16:1456e Kobashi Y, Okimoto N, Hara Y, Matsushima T. A case of mixed pulmonary infection with Mycobacterium tuberculosis and M. intracellulare due to familial prevalence. Nihon Kokyuki Gakkai Zasshi 2002;40:35e Yanagisawa T, Sugita H, Matsushima H, et al. Investigation of the cases that Mycobacterium tuberculosis and nontuberculous mycobacteriosis were detected simultaneously. Kekkaku 2002; 77: Fujii S, Terashita K. Three cases of mixed infection with Mycobacterium tuberculosis and nontuberculous mycobacteriosis. Kekkaku 2003;78: Takeda M, Ito W, Kobayashi N, et al. Co-existence of Mycobacterium tuberculosis and Mycobacterium intracellulare in one sputum sample. Intern Med 2008;47:1057e American Thoracic Society. Diagnostic standards and classification of tuberculosis in adults and children. Am J Respir Crit Care Med 2000;161:1376e Park S, Suh GY, Chung MP, et al. Clinical significance of Mycobacterium fortuitum isolated from respiratory specimens. Respir Med 2008;102:437e Kim S, Park EM, Kwon OJ, et al. Direct application of the PCR restriction analysis method for identifying NTM species in AFB smear-positive respiratory specimens. Int J Tuberc Lung Dis 2008;12:1344e Falk A, O Connor JB, Pratt PC, Webb WR, Wier JA, Wolinsky E. Classification of pulmonary tuberculosis. In: Diagnostic standards and classification of tuberculosis. 12th ed. New York: National Tuberculosis and Respiratory Disease Association; Kobashi Y, Fukuda M, Yoshida K, Miyashita N, Niki Y, Oka M. Chronic necrotizing pulmonary aspergillosis as a complication of pulmonary Mycobacterium avium complex disease. Respirology 2006;11:809e Kunst H, Wickremasinghe M, Wells A, Wilson R. Nontuberculous mycobacterial disease and Aspergillus-related lung disease in bronchiectasis. Eur Respir J 2006;28:352e Catanzaro A. Diagnosis, differentiating colonization, infection, and disease. Clin Chest Med 2002;23:599e Eckburg PB, Buadu EO, Stark P, Sarinas PS, Chitkara RK, Kuschner WG. Clinical and chest radiographic findings among persons with sputum culture positive for Mycobacterium gordonae: a review of 19 cases. Chest 2000;117:96e102.
Increasing Trend of Isolation of Non-Tuberculous Mycobacteria in a Tertiary University Hospital in South Korea
http://dx.doi.org/10.4046/trd.2012.72.5.409 ISSN: 1738-3536(Print)/2005-6184(Online) Tuberc Respir Dis 2012;72:409-415 CopyrightC2012. The Korean Academy of Tuberculosis and Respiratory Diseases. All rights
More informationClarithromycin-resistant Mycobacterium Shinjukuense Lung Disease: Case Report and Literature Review
Showa Univ J Med Sci 28 4, 373 377, December 2016 Case Report Clarithromycin-resistant Mycobacterium Shinjukuense Lung Disease: Case Report and Literature Review Makoto HAYASHI 1, Satoshi MATSUKURA 1,
More informationMycobacterium abscessus Lung Disease in a Patient with Kartagener Syndrome
CASE REPORT http://dx.doi.org/10.4046/trd.2014.77.3.136 ISSN: 1738-3536(Print)/2005-6184(Online) Tuberc Respir Dis 2014;77:136-140 Mycobacterium abscessus Lung Disease in a Patient with Kartagener Syndrome
More informationGeographical distribution and clinical relevance of nontuberculous mycobacteria in Croatia
Geographical distribution and clinical relevance of nontuberculous mycobacteria in Croatia M. Jankovic 1, M. Samarzija 1, I. Sabol 2, M. Jakopovic 1, V. Katalinic Jankovic 3, LJ. Zmak 3, B. Ticac 4, A.
More informationImplication of species change of Nontuberculous Mycobacteria during or after treatment
Lee et al. BMC Pulmonary Medicine (2017) 17:213 DOI 10.1186/s12890-017-0539-7 RESEARCH ARTICLE Open Access Implication of species change of Nontuberculous Mycobacteria during or after Jong Sik Lee 1, Jong
More informationDiagnosis of Pulmonary Tuberculosis and Nontuberculous Mycobacterial Lung Disease in Korea
REVIEW http://dx.doi.org/10.4046/trd.2014.77.1.1 ISSN: 1738-3536(Print)/2005-6184(Online) Tuberc Respir Dis 2014;77:1-5 Diagnosis of Pulmonary Tuberculosis and Nontuberculous Mycobacterial Lung Disease
More informationPrevalence of Gastroesophageal Reflux Disease in Patients With Nontuberculous Mycobacterial Lung Disease*
Original Research MYCOBACTERIAL DISEASE Prevalence of Gastroesophageal Reflux Disease in Patients With Nontuberculous Mycobacterial Lung Disease* Won-Jung Koh, MD; Jun Haeng Lee, MD; Yong Soo Kwon, MD;
More informationNontuberculous Mycobacteria (NTM)
Nontuberculous Mycobacteria (NTM) Bacteria, like plants and animals, have been classified into similar groups. The groups are called "families." One such family of bacteria is known as the Mycobacteriaceae.
More informationPathologic Findings of Surgically Resected Nontuberculous Mycobacterial Pulmonary Infection
The Korean Journal of Pathology 2010; 44: 56-62 DOI: 10.4132/KoreanJPathol.2010.44.1.56 Pathologic Findings of Surgically Resected Nontuberculous Mycobacterial Pulmonary Infection Hye-Jong Song Jung Suk
More informationNON-TUBERCULOUS MYCOBACTERIAL (NTM) INFECTIONS ISOLATED FROM BIRMINGHAM HEARTLANDS HOSPITAL: A CASE NOTES REVIEW.
NON-TUBERCULOUS MYCOBACTERIAL (NTM) INFECTIONS ISOLATED FROM BIRMINGHAM HEARTLANDS HOSPITAL: A CASE NOTES REVIEW. K. Clay 1, K. Bhatt 1, D. Burns 1, J. Evans 2, S. Gardiner 2, EG. Smith 2, P. Hawkey 2,
More informationNontuberculous Mycobacterial Lung Disease
Non-TB Mycobacterial Disease Jeffrey P. Kanne, MD Nontuberculous Mycobacterial Lung Disease Jeffrey P. Kanne, M.D. Consultant Disclosures Perceptive Informatics Royalties (book author) Amirsys, Inc. Wolters
More informationAntibiotic Treatment of Mycobacterium abscessus Lung Disease A Retrospective Analysis of 65 Patients
Antibiotic Treatment of Mycobacterium abscessus Lung Disease A Retrospective Analysis of 65 Patients Kyeongman Jeon 1, O Jung Kwon 1, Nam Yong Lee 2, Bum-Joon Kim 3, Yoon-Hoh Kook 3, Seung-Heon Lee 4,
More informationRapid Diagnosis of Tuberculosis and Multidrug Resistance Using a MGIT 960 System
Original Article Clinical Microbiology Ann Lab Med 2012;32:264-269 ISSN 2234-3806 eissn 2234-3814 Rapid Diagnosis of Tuberculosis and Multidrug Resistance Using a MGIT 960 System Won-Jung Koh, M.D. 1,
More informationIsolation of non-tuberculous mycobacteria at three rural settings in Zambia; a pilot study
ORIGINAL ARTICLE BACTERIOLOGY Isolation of non-tuberculous mycobacteria at three rural settings in Zambia; a pilot study P. C. A. M. Buijtels 1,2, M. A. B. van der Sande 3, S. Parkinson 4, H. A. Verbrugh
More informationSerodiagnosis of Mycobacterium avium complex pulmonary disease in the USA
ORIGINAL ARTICLE PULMONARY INFECTIONS Serodiagnosis of Mycobacterium avium complex pulmonary disease in the USA Seigo Kitada 1, Adrah Levin 2, Melissa Hiserote 3, Ron J. Harbeck 3, Chris A. Czaja 2,4,
More informationDOWNLOAD OR READ : NONTUBERCULOUS MYCOBACTERIA NTM PDF EBOOK EPUB MOBI
DOWNLOAD OR READ : NONTUBERCULOUS MYCOBACTERIA NTM PDF EBOOK EPUB MOBI Page 1 Page 2 nontuberculous mycobacteria ntm nontuberculous mycobacteria ntm pdf nontuberculous mycobacteria ntm patients and those
More informationAFB Identification Texas Approach
AFB Identification Texas Approach Ken Jost Texas Department of State Health Services 6th National Conference on Laboratory Aspects of TB June 21, 2010 DSHS-Austin TB Lab Customers & Samples Year 2009 175
More informationNontuberculous mycobacteria isolated from pulmonary specimens between 2004 and 2009: causative agent or not?
NEW MICROBIOLOGICA, 33, 399-403, 2010 Nontuberculous mycobacteria isolated from pulmonary specimens between 2004 and 2009: causative agent or not? Can Bicmen 1, Meral Coskun 1, Ayriz T. Gunduz 1, Gunes
More information2018 Vindico Medical Education. Non-tuberculous Mycobacteria: Circumventing Difficulties in Diagnosis and Treatment
Activity presentations are considered intellectual property. These slides may not be published or posted online without permission from Vindico Medical Education (cme@vindicocme.com). Please be respectful
More informationDiagnostic Evaluation of NTM and Bronchiectasis
Division of Pulmonary, Critical Care and Sleep Medicine Diagnostic Evaluation of NTM and Bronchiectasis Ashwin Basavaraj, MD, FCCP NTM patient education program November 9, 2016 Involves a combination
More informationClinical and Public Health Impact of Nucleic Acid Amplification Tests (NAATs) for Tuberculosis
Clinical and Public Health Impact of Nucleic Acid Amplification Tests (NAATs) for Tuberculosis Amit S. Chitnis, MD, MPH; Pennan M. Barry, MD, MPH; Jennifer M. Flood, MD, MPH. California Tuberculosis Controllers
More informationChronic Mycobacterium abscessus infection and lung function decline in cystic fibrosis
Journal of Cystic Fibrosis 9 (2010) 117 123 www.elsevier.com/locate/jcf Original article Chronic Mycobacterium abscessus infection and lung function decline in cystic fibrosis Charles R. Esther Jr., Denise
More informationMicroscopic Morphology in Smears Prepared from MGIT Broth Medium for Rapid Presumptive Identification of Mycobacterium tuberculosis
Annals of Clinical & Laboratory Science, vol. 33, no. 2, 2003 179 Microscopic Morphology in Smears Prepared from MGIT Broth Medium for Rapid Presumptive Identification of Mycobacterium tuberculosis complex,
More informationProfile of Tuberculosis Infection among Current HIV+ Patients at the Philippine General Hospital
Profile of Tuberculosis Infection among Current HIV+ Patients at the Albert B. Albay Jr., MD Jemylyn Garcia, MD Joel Santiaguel, MD UP- TB in the Philippines 6 th leading cause of morbidity and mortality
More informationSerial CT Findings of Nodular Bronchiectatic Mycobacterium avium Complex Pulmonary Disease With Antibiotic Treatment
Cardiopulmonary Imaging Original Research Lee et al. Serial CT of MAC Pulmonary Disease Cardiopulmonary Imaging Original Research Geewon Lee 1 Hyun Su Kim 1 Kyung Soo Lee 1 Won-Jung Koh 2 Kyeongman Jeon
More informationNatural history of Mycobacterium avium complex lung disease in untreated patients with stable course
ORIGINAL ARTICLE RESPIRATORY INFECTIONS Natural history of Mycobacterium avium complex lung disease in untreated patients with stable course Ji An Hwang 1,3, Sunyoung Kim 2,3, Kyung-Wook Jo 1 and Tae Sun
More informationHyun Su Kim, MD Kyung Soo Lee, MD Won-Jung Koh, MD Kyeongman Jeon, MD Eun Ju Lee, MD Hee Kang, MD Joonghyun Ahn, PhD. Purpose: Materials and Methods:
Note: This copy is for your personal non-commercial use only. To order presentation-ready copies for distribution to your colleagues or clients, contact us at www.rsna.org/rsnarights. Original Research
More informationStandardized Case Definition for Extrapulmonary Nontuberculous Mycobacteria Infections
Operational Guidance for Position Statement 17 ID 07: Standardized Case Definition for Extrapulmonary Nontuberculous Mycobacteria Infections Submission Date: April 28, 2017 Committee: Infectious Disease
More informationTB Intensive San Antonio, Texas August 7-10, 2012
TB Intensive San Antonio, Texas August 7-10, 2012 Nontuberculosis Mycobacterial Lung Disease David Griffith, MD August 8, 2012 David Griffith, MD has the following disclosures to make: No conflict of interests
More informationMycobacteriology William H. Benjamin, Jr.
Mycobacteriology William H. Benjamin, Jr. William H. Benjamin, PhD Department of Pathology UAB 1 Mycobacteria sp. Acid Fast Bacilli (AFB) Mycolic acids (C78-91) Waxes Obligate aerobes Slow growing days
More informationPost-bronchoscopy sputum: Improving the diagnostic yield in smear negative pulmonary TB
Respiratory Medicine (2011) 105, 1726e1731 available at www.sciencedirect.com journal homepage: www.elsevier.com/locate/rmed Post-bronchoscopy sputum: Improving the diagnostic yield in smear negative pulmonary
More informationDiagnosis and Treatment of Nontuberculous Mycobacterial Pulmonary Diseases
Diagnosis and Treatment of Nontuberculous Mycobacterial Pulmonary Diseases Jae Joon Yim, M.D. Sung Koo Han, M.D. Division of Pulmonary and Critical Care Medicine Department of Internal Medicine Seoul National
More informationSlowly Growing Nontuberculous Mycobacterial Infections
Slowly Growing Nontuberculous Mycobacterial Infections Charles L. Daley, MD National Jewish Health University of Colorado, Denver Disclosures Advisory Board Horizon, Johnson and Johnson, Otsuka and Spero
More informationHow Do I Manage Nontuberculous Mycobacterial (NTM) Lung Disease Patients?
How Do I Manage Nontuberculous Mycobacterial (NTM) Lung Disease Patients? David E. Griffith, M.D. Professor of Medicine University of Texas Health Science Center, Tyler Potential COI Statement I was a
More informationAppendix C. Recommendations for Counting Reported Tuberculosis Cases (Revised July 1997)
Appendix C Recommendations for Counting Reported Tuberculosis Cases (Revised July 1997) Since publication of the Recommendations for Counting Reported Tuberculosis Cases 1 in January 1977, numerous changes
More informationShannon Kasperbauer, M.D. National Jewish Health University of Colorado Health Sciences Center. Property of Presenter. Not for Reproduction
Shannon Kasperbauer, M.D. National Jewish Health University of Colorado Health Sciences Center Consultant: Johnson and Johnson Speaker/consultant: Insmed Examine characteristics of the RGM Define the main
More informationTB Intensive Houston, Texas October 15-17, 2013
TB Intensive Houston, Texas October 15-17, 2013 Nontuberculous Mycobacterial Lung Disease David Griffith, MD October 15, 2013 David Griffith, MD has the following disclosures to make: No conflict of interests
More informationNontuberculous Mycobacterial Pulmonary Diseases in Immunocompetent Patients
Nontuberculous Mycobacterial Pulmonary Diseases in Immunocompetent Patients Won-Jung Koh, MD 1 O Jung Kwon, MD 1 Kyung Soo Lee, MD 2 Nontuberculous mycobacterial (NTM) infections are an increasingly recognized
More informationCharacteristics of Mycobacterium
Mycobacterium Characteristics of Mycobacterium Very thin, rod shape. Culture: Aerobic, need high levels of oxygen to grow. Very slow in grow compared to other bacteria (colonies may be visible in up to
More informationAcute necrotizing pneumonia combined with parapneumonic effusion caused by Mycobacterium lentiflavum: a case report
Lee et al. BMC Infectious Diseases (2015) 15:354 DOI 10.1186/s12879-015-1100-z CASE REPORT Open Access Acute necrotizing pneumonia combined with parapneumonic effusion caused by Mycobacterium lentiflavum:
More informationLaboratory Diagnostic Techniques. Hugo Donaldson Consultant Microbiologist Imperial College Healthcare NHS Trust
Laboratory Diagnostic Techniques Hugo Donaldson Consultant Microbiologist Imperial College Healthcare NHS Trust Learning Objectives 1) When to consider a diagnosis of TB 2) When to consider a referral
More informationTreatment of Mycobacterium avium Complex Pulmonary Disease
REVIEW https://doi.org/10.4046/trd.2018.0060 ISSN: 1738-3536(Print)/2005-6184(Online) Tuberc Respir Dis 2019;82:15-26 Treatment of Mycobacterium avium Complex Pulmonary Disease Yong-Soo Kwon, M.D. 1, Won-Jung
More informationNontuberculous Mycobacteria
Nontuberculous Mycobacteria Epidemiology and Clinical Management Kevin L. Winthrop, MD, MPH Associate Professor, Divisions of Infectious Diseases, Public Health and Preventive Medicine Oregon Health &
More informationOverview of Mycobacterial Culture, Identification, and Drug Susceptibility Testing
Overview of Mycobacterial Culture, Identification, and Drug Susceptibility Testing 1. Essentials for the Mycobacteriology Laboratory: Promoting Quality Practices 1.1 Overview: Mycobacterial Culture, Identification,
More informationNontuberculous mycobacterial disease and Aspergillus-related lung disease in bronchiectasis
Eur Respir J 2006; 28: 352 357 DOI: 10.1183/09031936.06.00139005 CopyrightßERS Journals Ltd 2006 Nontuberculous mycobacterial disease and Aspergillus-related lung disease in bronchiectasis H. Kunst*, M.
More informationEPIDEMIOLOGICAL STUDY ON FACTORS AFFECTING THE HOSPITALIZATION PERIOD OF PATIENTS WITH ACTIVE TUBERCULOSIS
572 83 8 2008 8 Original Article EPIDEMIOLOGICAL STUDY ON FACTORS AFFECTING THE HOSPITALIZATION PERIOD OF PATIENTS WITH ACTIVE TUBERCULOSIS Tadahiko FUJINO, Hisae FUSEGAWA, Mai NISHIUMI, Yasuyuki OKUBO,
More informationAppendix B. Recommendations for Counting Reported Tuberculosis Cases (Revised July 1997)
Appendix B Recommendations for Counting Reported Tuberculosis Cases (Revised July 1997) Since publication of the Recommendations for Counting Reported Tuberculosis Cases 1 in January 1977, numerous changes
More informationCommunicable Disease Control Manual Chapter 4: Tuberculosis
Provincial TB Services 655 West 12th Avenue Vancouver, BC V5Z 4R4 www.bccdc.ca Communicable Disease Control Manual Definitions Page 1 2.0 DEFINITIONS Many of the definitions that follow are taken from
More informationOriginal Article Tree-in-bud pattern of chest CT images for diagnosis of Mycobacterium abscesses
Int J Clin Exp Med 2015;8(10):18705-18712 www.ijcem.com /ISSN:1940-5901/IJCEM0013538 Original Article Tree-in-bud pattern of chest CT images for diagnosis of Mycobacterium Haiqing Chu 1, Bing Li 1, Lan
More informationChanges in cholesterol level correlate with the course of pulmonary nontuberculous mycobacterial disease
Original Article Changes in cholesterol level correlate with the course of pulmonary nontuberculous mycobacterial disease Ji Young Hong 1,2, Go Eun Yang 3, Yousang Ko 2,4, Yong Bum Park 2,4, Yun Su Sim
More informationPrevalence and risk factors for chronic co-infection in pulmonary Mycobacterium avium complex disease
To cite: Fujita K, Ito Y, Hirai T, et al. Prevalence and risk factors for chronic coinfection in pulmonary Mycobacterium avium complex disease. BMJ Open Resp Res 2014;1:e000050. doi:10.1136/bmjresp-2014-000050
More informationRyo Takahashi 1,2,3, Taiki Fujiwara 1,2, Hisami Yamakawa 1,2. Introduction
Case Report Completion pneumonectomy after fenestration for empyema due to nontuberculous mycobacteriosis associated with destroyed lung as a result of cancer surgery Ryo Takahashi 1,2,3, Taiki Fujiwara
More informationConsolidations in Nodular Bronchiectatic Mycobacterium Avium Complex Lung Disease: Mycobacterium Avium Complex or Other Infection?
Original Article DOI 10.3349/ymj.2010.51.4.546 pissn: 0513-5796, eissn: 1976-2437 Yonsei Med J 51(4):546-551, 2010 Consolidations in Nodular Bronchiectatic Mycobacterium Avium Complex Lung Disease: Mycobacterium
More informationIsolation of non tuberculous mycobacteria among tuberculosis patients during a five year. period in Croatia
Isolation of non tuberculous mycobacteria among tuberculosis patients during a five year period in Croatia Ljiljana Zmak 1, Mihaela Obrovac 1, Mateja Jankovic Makek 2, Ivan Sabol 3 and Vera Katalinic Jankovic
More informationCHAPTER 3: DEFINITION OF TERMS
CHAPTER 3: DEFINITION OF TERMS NOTE: TB bacteria is used in place of Mycobacterium tuberculosis and Mycobacterium tuberculosis complex in most of the definitions presented here. 3.1 Acid-fast bacteria
More informationIs the Initial Size of Tuberculous Lymphadenopathy associated with Lymph Node Enlargement during Treatment?
Brief Communication https://doi.org/10.3947/ic.2017.49.2.130 Infect Chemother 2017;49(2):130-134 ISSN 2093-2340 (Print) ISSN 2092-6448 (Online) Infection & Chemotherapy Is the Initial Size of Tuberculous
More informationDifferent characteristics of tuberculous pleural effusion according to pleural fluid cellular predominance and loculation
Original Article Different characteristics of tuberculous pleural effusion according to pleural fluid cellular predominance and loculation Jaehee Lee 1, Jae Kwang Lim 2, Seung Soo Yoo 1, Shin Yup Lee 1,
More informationRecent Advances in Tuberculosis and Nontuberculous Mycobacteria Lung Disease
http://dx.doi.org/10.4046/trd.2013.74.6.251 ISSN: 1738-3536(Print)/2005-6184(Online) Tuberc Respir Dis 2013;74:251-255 CopyrightC2013. The Korean Academy of Tuberculosis and Respiratory Diseases. All rights
More informationThe performance of interferon-gamma release assay in nontuberculous mycobacterial diseases: a retrospective study in China
Wang et al. BMC Pulmonary Medicine (2016) 16:163 DOI 10.1186/s12890-016-0320-3 RESEARCH ARTICLE The performance of interferon-gamma release assay in nontuberculous mycobacterial diseases: a retrospective
More informationHIV-negative pulmonary disease caused by nontuberculous mycobacteria in Southern Brazil: clinical and microbiological characterization
Original Article HIV-negative pulmonary disease caused by nontuberculous mycobacteria in Southern Brazil: clinical and microbiological characterization Fernanda Guioti Puga 1, Renata Helena Candido Pocente
More informationMycobacterium intracellulare Pleurisy Identified on Liquid Cultures of the Pleural Fluid and Pleural Biopsy
http://dx.doi.org/10.4046/trd.2013.74.3.124 ISSN: 1738-3536(Print)/2005-6184(Online) Tuberc Respir Dis 2013;74:124-128 CopyrightC2013. The Korean Academy of Tuberculosis and Respiratory Diseases. All rights
More informationAIDS. 1) Mycobacterium avium MRI (T2WI) HTLV-1 AIDS. Key words: Mycobacterium avium AIDS. Mycobacterium. complex MAC M. avium M.
2008 193 AIDS Mycobacterium avium 1) 2) 3) 4) 4) 3) 3) 3) 5) 1) 6) 1) 2) 3) 4) 5) 6) 20 1 30 20 6 13 46 MRI (T2WI) MRI 5 Mycobacterium avium M. avium HIV HTLV-1 AIDS AIDS Key words: Mycobacterium avium
More informationAppendix B. Recommendations for Counting Reported Tuberculosis Cases (Revised July 1997)
Appendix B Recommendations for Counting Reported Tuberculosis Cases (Revised July 1997) Since publication of the Recommendations for Counting Reported Tuberculosis Cases 1 in January 1977, numerous changes
More informationThe MODS Assay for Detection of TB and TB Drug Resistance: A Multi-center Study
The MODS Assay for Detection of TB and TB Drug Resistance: A Multi-center Study microscopic observation drug susceptibility Susan E. Dorman, MD Johns Hopkins University Afranio L. Kritski, MD, PhD Federal
More informationNon-tuberculous mycobacterial pulmonary infections
Clin Chest Med 23 (2002) 369 376 Non-tuberculous mycobacterial pulmonary infections Alimuddin I. Zumla PhD, FRCP a, *, John Grange, MD, MSc b a Centre for Infectious Diseases and International Health,
More informationNovel Therapies for NTM
NTM Lecture Series for Providers Novel Therapies for NTM Kenneth N Olivier, MD, MPH Laboratory of Chronic Airway Infection Chief, Pulmonary Branch/DIR October 20, 2017 Disclosures Past: Cooperative Research
More informationMYCOBACTERIA. Pulmonary T.B. (infect bird)
MYCOBACTERIA SPP. Reservoir Clinical Manifestation Mycobacterium tuberculosis Human Pulmonary and dissem. T.B. M. lepra Human Leprosy M. bovis Human & cattle T.B. like infection M. avium Soil, water, birds,
More informationCDPH - CTCA Joint Guidelines Guideline for Micobacteriology Services In California
CDPH - CTCA Joint Guidelines Guideline for Micobacteriology Services In California These guidelines are intended to be used as an educational aid to help clinicians make informed decisions about patient
More informationTB Laboratory for Nurses
TB Laboratory for Nurses Shea Rabley, RN, MN Consultant Mayo Clinic Center for Tuberculosis 2014 MFMER slide-1 Disclosures None 2014 MFMER slide-2 Objectives Participants will be able to: 1. Name 2 safety
More informationFactors Associated with Indeterminate and False Negative Results of QuantiFERON-TB Gold In-Tube Test in Active Tuberculosis
http://dx.doi.org/10.4046/trd.2012.72.5.416 ISSN: 1738-3536(Print)/2005-6184(Online) Tuberc Respir Dis 2012;72:416-425 CopyrightC2012. The Korean Academy of Tuberculosis and Respiratory Diseases. All rights
More informationTitle: Cefoxitin Continuous Infusion for Lung Infection Caused by M. abscessus group
AAC Accepts, published online ahead of print on 14 April 2014 Antimicrob. Agents Chemother. doi:10.1128/aac.02763-14 Copyright 2014, American Society for Microbiology. All Rights Reserved. 1 Title: Cefoxitin
More informationA Vietnamese woman with a 2-week history of cough
Delphine Natali 1, Hai Tran Pham 1, Hung Nguyen The 2 delphinenatali@gmail.com Case report A Vietnamese woman with a 2-week history of cough A 52-year-old nonsmoker Vietnamese woman without any past medical
More informationClinical characteristics of health care-associated pneumonia in a Korean teaching hospital
Respiratory Medicine (2010) 104, 1729e1735 available at www.sciencedirect.com journal homepage: www.elsevier.com/locate/rmed Clinical characteristics of health care-associated pneumonia in a Korean teaching
More informationMycobacterium szulgai: a rare pathogen. Description of the first pulmonary case reported in Argentina ACCEPTED
JCM Accepts, published online ahead of print on 27 June 2007 J. Clin. Microbiol. doi:10.1128/jcm.00148-07 Copyright 2007, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights
More informationMycobacterial diseases developed during anti-tumour necrosis factor-a therapy
ORIGINAL ARTICLE PULMONARY INFECTIONS Mycobacterial diseases developed during anti-tumour necrosis factor-a therapy Jung-Wan Yoo 1, Kyung-Wook Jo 1, Bo-Hyung Kang 1, Mi Young Kim 2, Bin Yoo 3, Chang-Keun
More informationStandard Diagnostic Procedure for Tuberculosis: A Review
ISSN: 2249 8656 www.stmjournals.com Standard Diagnostic Procedure for Tuberculosis: A Review Suresh Jaiswal*, Jay Prakash Sah, Bhoopendra Sharma Department of Medical Lab Science, School of Health and
More informationFirst described as a respiratory tract pathogen. Clinical relevance of Mycobacterium malmoense isolation in the Netherlands
Eur Respir J 2009; 34: 926 931 DOI: 10.1183/09031936.00039009 CopyrightßERS Journals Ltd 2009 Clinical relevance of Mycobacterium malmoense isolation in the Netherlands W. Hoefsloot*, J. van Ingen*,#,
More informationProvoost et al. BMC Infectious Diseases (2018) 18:659 (Continued on next page)
Provoost et al. BMC Infectious Diseases (2018) 18:659 https://doi.org/10.1186/s12879-018-3559-x RESEARCH ARTICLE Open Access A retrospective study of factors associated with treatment decision for nontuberculous
More informationClinical Impact of Nucleic Acid Amplification Testing in the Diagnosis of Mycobacterium Tuberculosis: A 10-Year Longitudinal Study
Open Forum Infectious Diseases MAJOR ARTICLE Clinical Impact of Nucleic Acid Amplification Testing in the Diagnosis of Mycobacterium Tuberculosis: A 10-Year Longitudinal Study Kassem Bourgi, 1 Jaimin Patel,
More informationMycobacterium avium Complex Organisms Predominantly Colonize in the Bathtub Inlets of Patients Bathrooms
Jpn. J. Infect. Dis., 62, 182-186, 2009 Original Article Mycobacterium avium Complex Organisms Predominantly Colonize in the Bathtub Inlets of Patients Bathrooms Yukiko Nishiuchi*, Aki Tamaru 1, Seigo
More informationPeritoneal dialysis associated peritonitis secondary to Mycobacterium fortuitum
Case Reports Peritoneal dialysis associated peritonitis secondary to Mycobacterium fortuitum Paula McKenzie MD, David Sotello MD, Kunal Parekh MD, Kristen Fuhrmann PharmD, Richard Winn MD Abstract We report
More informationFrequency and clinical implications of the isolation of rare nontuberculous mycobacteria
Kim et al. BMC Infectious Diseases (2015) 15:9 DOI 10.1186/s12879-014-0741-7 RESEARCH ARTICLE Open Access Frequency and clinical implications of the isolation of rare nontuberculous mycobacteria Junghyun
More informationDisseminated Mycobacterium avium Complex Infection in a Non-HIV-infected Patient Undergoing Continuous Ambulatory Peritoneal Dialysis
Korean J Lab Med 2010;30:166-70 DOI 10.3343/kjlm.2010.30.2.166 Case Report Clinical Microbiology Disseminated Mycobacterium avium Complex Infection in a Non-HIV-infected Patient Undergoing Continuous Ambulatory
More informationKey words: azithromycin; bronchiectasis; clarithromycin; clofazimine; ethambutol; Mycobacterium avium
Treatment of Mycobacterium aviumintracellulare complex Lung Disease With a Macrolide, Ethambutol, and Clofazimine* Stephen K. Field, MD, CM, FCCP; Robert L. Cowie, MD, MSc Background: Mycobacterium avium-intracellulare
More informationHypothesis on the Evolution of Cavitary Lesions in Nontuberculous Mycobacterial Pulmonary Infection: Thin-Section CT and Histopathologic Correlation
CT of Nontuberculous Mycobacterial Pulmonary Infection Tae Sung Kim 1 Won-Jung Koh 2 Joungho Han 3 Myung Jin Chung 1 Ju Hyun Lee 1 Kyung Soo Lee 1 O Jung Kwon 2 Kim TS, Koh W-J, Han J, et al. Received
More informationMYCOBACTERIOLOGY SERVICE MANUAL
MYCOBACTERIOLOGY SERVICE MANUAL The Office of Laboratory Services (OLS) provides primary isolation and identification of Mycobacterium species in human diagnostic specimens. Reference specimens of AFB
More informationMycobacterium fortuitum,
2009 177 Mycobacterium fortuitum 1 1) 2) 3) 1) 1) 4) 4) 5) 2) 1) 1) 2) 3) 4) 5) 21 3 16 21 7 1 Mycobacterium fortuitum 1 39 BHI 2 Ziehl Neelsen M. fortuitum MIC CPFX 0.2 mg/ml, MINO 0.78 mg/ml, CAM 100
More informationTreatment outcomes and survival based on drug resistance patterns in multidrug-resistant
Treatment outcomes and survival based on drug resistance patterns in multidrug-resistant tuberculosis Doh Hyung Kim, Hee Jin Kim, Seung-Kyu Park, Suck-Jun Kong, Young Sam Kim, Tae-Hyung Kim, Eun Kyung
More informationTB Updates for the Physician Rochester, Minnesota June 19, 2009
TB Updates for the Physician Rochester, Minnesota June 19, 2009 Mycobacterial Laboratory Science Update Nancy L. Wengenack, Ph.D. Associate Professor of Laboratory Medicine and Pathology Division of Clinical
More informationMycobacterium avium complex disease: prognostic implication of high-resolution computed tomography findings
Eur Respir J 2008; 32: 147 152 DOI: 10.1183/09031936.00074207 CopyrightßERS Journals Ltd 2008 Mycobacterium avium complex disease: prognostic implication of high-resolution computed tomography findings
More informationUsefulness of Induced Sputum and Fibreoptic Bronchoscopy Specimens in the Diagnosis of Pulmonary Tuberculosis
The Journal of International Medical Research 2005; 33: 260 265 Usefulness of Induced Sputum and Fibreoptic Bronchoscopy Specimens in the Diagnosis of Pulmonary Tuberculosis L SAGLAM 1, M AKGUN 1 AND E
More informationNucleic Acid Amplification Testing for the Diagnosis of TB
Roche Nucleic Acid Amplification Testing for the Diagnosis of TB David Warshauer, PhD Deputy Director, Communicable Diseases Wisconsin State Laboratory of Hygiene 19 th /20 th Century Traditional Algorithm
More informationComparison of CT findings between MDR-TB and XDR-TB
Comparison of CT findings between MDR-TB and XDR-TB Poster No.: C-0757 Congress: ECR 2017 Type: Authors: Keywords: DOI: Scientific Exhibit K. Yoon, H. Soohee; Changwon-si/KR Thorax, Lung, Respiratory system,
More informationNucleic Acid Amplification Test for Tuberculosis. Heidi Behm, RN, MPH Acting TB Controller HIV/STD/TB Program Oregon, Department of Health Services
Nucleic Acid Amplification Test for Tuberculosis Heidi Behm, RN, MPH Acting TB Controller HIV/STD/TB Program Oregon, Department of Health Services What is this test? Nucleic Acid Amplification Test (NAAT)
More informationSix-month Therapy with Aerosolized Interferon-γfor Refractory Multidrug-Resistant Pulmonary Tuberculosis
J Korean Med Sci 2004; 19: 167-71 ISSN 1011-8934 Copyright The Korean Academy of Medical Sciences Six-month Therapy with Aerosolized Interferon-γfor Refractory Multidrug-Resistant Pulmonary Tuberculosis
More informationCardiovascular Center Grand Rounds. December 15, 2016
Cardiovascular Center Grand Rounds December 15, 2016 Agenda Overview of Heater-Cooler Device Issue NTM Infection Incidence Chronology of Events and Communications Risk Management Implications Q&A NTM Grand
More informationStacy White, PhD May 12, TB for Community Providers. Phoenix, Arizona
Role of the Laboratory in TB Diagnosis Stacy White, PhD May 12, 2015 TB for Community Providers May 12, 2015 Phoenix, Arizona EXCELLENCE EXPERTISE INNOVATION Stacy White, PhD has the following disclosures
More informationP ulmonary non-tuberculous mycobacteria (NTM) infection
661 TUBERCULOSIS Isolation prevalence of pulmonary non-tuberculous mycobacteria in Ontario, 1997 2003 Theodore K Marras, Pamela Chedore, Alicia M Ying, Frances Jamieson... See end of article for authors
More informationNon-Tuberculous Mycobacteria in Bronchiectasis: Prevalence and Patient Characteristics. Papworth Hospital, Cambridge, UK
ERJ Express. Published on June 28, 2006 as doi: 10.1183/09031936.06.00149805 Non-Tuberculous Mycobacteria in Bronchiectasis: Prevalence and Patient Characteristics SJ Fowler 1, J French 1, NJ Screaton
More informationBest Practices for Pulmonary Nontuberculous Mycobacteria
Best Practices for Pulmonary Nontuberculous Mycobacteria June 2017 Public Health Ontario Public Health Ontario is a Crown corporation dedicated to protecting and promoting the health of all Ontarians and
More information